Total expenditure on pharmaceuticals rose 4.43% to USD 5,038 mil in Sweden in 2017, according to OECD.
Historically, total expenditure on pharmaceuticals in Sweden reached an all time high of USD 5,665 mil in 2011 and an all time low of USD 130 mil in 1970.
Sweden has been ranked 13th within the group of 30 countries we follow in terms of total expenditure on pharmaceuticals, 2 places above the position seen 10 years ago.
Total Expenditure on Pharmaceuticals (USD) | Unit | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 |
Australia | USD mil | 11,386 | 10,142 | 9,475 | 11,124 | 11,091 | ... | |||||||||||||||
China | USD mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... |
Denmark | USD mil | 3,561 | 3,628 | 3,303 | 3,114 | 3,380 | ||||||||||||||||
Finland | USD mil | 2,699 | 2,731 | 2,554 | 2,484 | 2,631 | ... | |||||||||||||||
Germany | USD mil | 41,848 | 43,265 | 40,522 | 38,723 | 41,757 | ... | |||||||||||||||
Iceland | USD mil | 213 | 195 | 190 | 209 | 254 | ||||||||||||||||
Indonesia | USD mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... |
Japan | USD mil | 70,503 | 58,550 | 56,155 | 55,827 | 58,523 | ... | |||||||||||||||
Netherlands | USD mil | 5,710 | 5,579 | 5,116 | 4,859 | 5,122 | ... | |||||||||||||||
New Zealand | USD mil | 756 | 769 | 720 | 741 | 888 | ||||||||||||||||
Norway | USD mil | 3,278 | 3,111 | 2,794 | 2,842 | 3,167 | ||||||||||||||||
Papua New Guinea | USD mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... |
Russia | USD mil | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... |
Sweden | USD mil | 5,571 | 5,312 | 4,994 | 4,824 | 5,038 | ||||||||||||||||
USA | USD mil | 326,988 | ... | ... | ... | ... | ... | ... |